Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04630821 · ClinicalTrials.gov registry record · NA
Utilizing Topical Sodium Hypochlorite to Ameliorate Radiation Dermatitis
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04630821: Clinical Trial NA study, sponsored by Northwestern University.
NCT04630821 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04630821, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The objective of the pilot study is to determine compliance, acceptability, and feasibility of using topical sodium hypochlorite to ameliorate or reduce radiation dermatitis, and to collect preliminary data and estimates for planning a larger efficacy study. This 3-week single-arm pilot study will collect information on subject treatment compliance and feedback from subjects (and nurses/subject's treating oncologist) on the acceptability of the use of the treatment. We will also collect data on Common Terminology Criteria for Adverse Events and patient reported outcomes measured using the pain and pruritus PROMIS short-form tools and patient reported outcomes, measured using the Dermatology Life Quality Index (DLQI) tool.
Primary Outcome
Compliance will be measured as the proportion of subjects who complete 80% or more of the compresses. We will consider the study 'successful' if ≥ 80% of patients complete 80% or more of the compresses.
Interventions
- OTHER Dilute Sodium Hypochlorite solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-02-08 |
| Est. Completion | 2022-04-25 |
| Phase | NA |
Why NCT04630821 stopped before completion
NCT04630821 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Dilute Sodium Hypochlorite solution is the first listed.
NCT04630821 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04630821 about?
NCT04630821 is a clinical study titled "Utilizing Topical Sodium Hypochlorite to Ameliorate Radiation Dermatitis". The objective of the pilot study is to determine compliance, acceptability, and feasibility of using topical sodium hypochlorite to ameliorate or reduce radiation dermatitis, and to collect preliminary data and estimates for planning a larger efficacy study. This 3-week single-arm pilot study will ...
What is the current status of trial NCT04630821?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-02-08. Estimated completion is 2022-04-25.
What interventions are being tested in trial NCT04630821?
The interventions under investigation include: Dilute Sodium Hypochlorite solution (OTHER).
Who is sponsoring clinical trial NCT04630821?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04630821's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI